Hypoxia and necrosis in rat 9L glioma and Morris 7777 hepatoma tumors: comparative measurements using EF5 binding and the Eppendorf needle electrode.
暂无分享,去创建一个
S M Evans | C. Koch | W. T. Jenkins | S. Evans | C J Koch | W T Jenkins
[1] J. Overgaard,et al. The importance of determining necrotic fraction when studying the effect of tumour volume on tissue oxygenation. , 1995, Acta oncologica.
[2] C. Koch,et al. Oxygen dependence of cellular uptake of EF5 [2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl)a cet amide] : analysis of drug adducts by fluorescent antibodies vs bound radioactivity. , 1995, British Journal of Cancer.
[3] B. Fish,et al. Correlation of radiobiological assays of hypoxic fraction with phosphorus-31 magnetic resonance spectroscopy across multiple tumor lines. , 1995, Radiation research.
[4] A. Alavi,et al. Noninvasive detection of tumor hypoxia using the 2-nitroimidazole [18F]EF1. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[5] C. Koch,et al. Detection of individual hypoxic cells in multicellular spheroids by flow cytometry using the 2-nitroimidazole, EF5, and monoclonal antibodies. , 1996, International journal of radiation oncology, biology, physics.
[6] J. Leith,et al. Cellular radiosensitivity of a rat brain tumor , 1975, Cancer.
[7] D. Hedley,et al. Heterogeneity of tumor oxygenation: relationship to tumor necrosis, tumor size, and metastasis. , 1998, International journal of radiation oncology, biology, physics.
[8] C. Grau,et al. Relationship between radiobiological hypoxia in tumors and electrode measurements of tumor oxygenation. , 1994, International journal of radiation oncology, biology, physics.
[9] Susan M. Chang,et al. Necrosis as a prognostic factor in glioblastoma multiforme , 1996, Cancer.
[10] D. Hirst,et al. Changes in misonidazole binding with hypoxic fraction in mouse tumors. , 1985, International journal of radiation oncology, biology, physics.
[11] C. Koch,et al. Identification of hypoxia in cells and tissues of epigastric 9L rat glioma using EF5 [2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl) acetamide]. , 1995, British Journal of Cancer.
[12] T. L. James,et al. Correlations between in vivo 31P MRS measurements, tumor size, cell survival, and hypoxic fraction in the murine EMT6 tumor , 1992, Magnetic resonance in medicine.
[13] P. Olive,et al. Hypoxic fractions measured in murine tumors and normal tissues using the comet assay. , 1994, International journal of radiation oncology, biology, physics.
[14] T. Cremer,et al. Laser microirradiation of Chinese hamster cells at wavelength 365 nm: effects of psoralen and caffeine. , 1981, Radiation research.
[15] M. Fernö,et al. Urokinase‐plasminogen‐activator levels and prognosis in 69 soft‐tissue sarcomas , 1996, International journal of cancer.
[16] T W Griffin,et al. Imaging of hypoxia in human tumors with [F-18]fluoromisonidazole. , 1992, International journal of radiation oncology, biology, physics.
[17] S. Patchett,et al. Identifying Stage B colorectal cancer patients at high risk of tumor recurrence and death , 1997, Diseases of the colon and rectum.
[18] M. Dewhirst,et al. Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. , 1997, International journal of radiation oncology, biology, physics.
[19] J. Overgaard,et al. Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. , 1996, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[20] P Vaupel,et al. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. , 1996, Cancer research.
[21] R. Gray,et al. Tumor necrosis is a prognostic predictor for early recurrence and death in lymph node-positive breast cancer: a 10-year follow-up study of 728 Eastern Cooperative Oncology Group patients. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] H. Morris. Studies on the development, biochemistry, and biology of experimental hepatomas. , 1965, Advances in cancer research.
[23] D. Neuberg,et al. Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] L. Harwell,et al. Detection of hypoxic cells by monoclonal antibody recognizing 2-nitroimidazole adducts. , 1993, Cancer research.
[25] R. Hill,et al. Comparing techniques of measuring tumor hypoxia in different murine tumors: Eppendorf pO2 Histograph, [3H]misonidazole binding and paired survival assay. , 1996, Radiation research.
[26] C. Koch,et al. Radiolytic reduction of protein and nonprotein disulfides in the presence of formate: a chain reaction. , 1991, Archives of biochemistry and biophysics.
[27] A. Fyles,et al. Oxygenation predicts radiation response and survival in patients with cervix cancer. , 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[28] S M Evans,et al. Interlaboratory variation in oxygen tension measurement by Eppendorf “Histograph” and comparison with hypoxic marker , 1997, Journal of surgical oncology.
[29] S. Michaelson,et al. Evidence for an unconventional radiosensitivity of rat 9L subcutaneous tumors. , 1980, Radiation research.
[30] J. Raleigh,et al. Dynamic measurements of hexafluoromisonidazole (CCI-103F) retention in mouse tumours by 1H/19F magnetic resonance spectroscopy. , 1990, International journal of radiation biology.
[31] B. Gasser,et al. Blood vessel invasion is a major prognostic factor in resected non-small cell lung cancer. , 1996, The Annals of thoracic surgery.
[32] C. Sehgal,et al. Use of power Doppler ultrasound-guided biopsies to locate regions of tumour hypoxia. , 1997, British Journal of Cancer.
[33] G. Rosner,et al. Quantification of CCI-103F labeling heterogeneity in canine solid tumors. , 1997, International journal of radiation oncology, biology, physics.
[34] M. Dewhirst,et al. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. , 1996, Cancer research.
[35] C. Koch,et al. 2-Nitroimidazole (EF5) binding predicts radiation resistance in individual 9L s.c. tumors. , 1996, Cancer research.
[36] L. Golberg,et al. Non-invasive assessment of human tumour hypoxia with 123I-iodoazomycin arabinoside: preliminary report of a clinical study. , 1992, British Journal of Cancer.
[37] J. Sham,et al. Evaluation of cervical nodal necrosis in nasopharyngeal carcinoma by computed tomography: Incidence and prognostic significance , 1997, Head & neck.
[38] L. H. Gray,et al. The Histological Structure of Some Human Lung Cancers and the Possible Implications for Radiotherapy , 1955, British Journal of Cancer.
[39] T L Phillips,et al. Oxygen in human tumors: correlations between methods of measurement and response to therapy. Summary of a workshop held November 19-20, 1992, at the National Cancer Institute, Bethesda, Maryland. , 1993, Radiation research.
[40] R. Hill,et al. Detection of hypoxic fractions in murine tumors by comet assay: comparison with other techniques. , 1995, Radiation research.
[41] J. Griffiths,et al. Preclinical evaluation of the fluorinated 2-nitroimidazole N-(2-hydroxy-3,3,3-trifluoropropyl)-2-(2-nitro-1-imidazolyl) acetamide (SR-4554) as a probe for the measurement of tumor hypoxia. , 1997, Cancer research.
[42] S. R. Parker,et al. Cyanine dye labeling reagents--carboxymethylindocyanine succinimidyl esters. , 1990, Cytometry.
[43] C. Koch,et al. Biodistribution of the nitroimidazole EF5 (2-[2-nitro-1H-imidazol-1-yl]-N-(2,2,3,3,3-pentafluoropropyl) acetamide) in mice bearing subcutaneous EMT6 tumors. , 1996, The Journal of pharmacology and experimental therapeutics.
[44] B. Wouters,et al. Cells at intermediate oxygen levels can be more important than the "hypoxic fraction" in determining tumor response to fractionated radiotherapy. , 1997, Radiation research.
[45] P Vaupel,et al. Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix. , 1993, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[46] C. Koch,et al. Direct relationship between radiobiological hypoxia in tumors and monoclonal antibody detection of EF5 cellular adducts , 1996, International journal of cancer.